Prevacid Articles
Teva returns to profit, as 4th quarter 2009 sales leap 33%
16 February 2010
Takeda’s 3rd quarter profits hit by in-licensing costs and sales declines for Actos and Prevacid
4 February 2010
Novartis posts 50% 4th-qtr 2009 profits rise and promotes drugs chief Jimenez to CEO; other top changes
26 January 2010
Teva files suit against Momenta/Sandoz over Copaxone, OK for generic Prevacid in USA for Teva and Mylan
11 November 2009
Japanese drug majors deliver mixed first-half results
2 November 2009
Americans with heartburn paying too much for Nexium's 'Purple Pill,' claims Consumer Reports
30 October 2009
Record sales balanced by costs for Takeda
27 May 2009
Novartis gets FDA approval for OTC Prevacid
15 May 2009
Japan stock market week to April 6, 2009
7 April 2009
Japan stock market week to March 23, 2009
30 March 2009
Takeda files Japanese NDA for H. Pylori combo
30 March 2009
Japan stock market week to Jan 19, 2009
26 January 2009
Teva cannot sell generic Prevacid until Nov 2009
17 November 2008
Takeda's recurring profit down 70%
10 November 2008
Japan stock market week to Oct 27, 2008
3 November 2008
Japan stock market week to July 21, 2008
28 July 2008
Japan stock market week to July 7, 2008
14 July 2008
High EE healing rate for TAK-360MR
26 May 2008
Maximum 10% generic Rxing in Japan
5 May 2008
Japan stock market week to Aril 21, 2008
28 April 2008
Rx-to-OTC switching making comeback
21 April 2008
Japan stock market week to March 24, 2008
31 March 2008
Amgen sells Takeda Japanese rights to 13 drugs in a deal that could be worth up to $1.2B
11 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Takeda set for $18.5B sales 2015, R&I says
28 January 2008
Japan stock market week to Oct 22, 2007
29 October 2007
Japan stock market week to April 23, 2007
30 April 2007
Abbott's 1st-qtr profit drops 19% to $697.5M
23 April 2007
Liponex' CRD5 yields solid Ph I/II trial results
23 April 2007
Japan stock market week to April 16, 2007
23 April 2007
Japan stock market week to Jan 29, 2007
5 February 2007
Abbott suffers 4th-qtr $0.37 LPS on Kos buy
5 February 2007
Japan stock market week to Dec 11, 2006
18 December 2006
Takeda's Takepron for injection OKed in Japan
30 October 2006
Japan stock market week to Oct 23, 2006
30 October 2006
Japan stock market week to July 24, 2006
26 July 2006
Strong data for AtstraZeneca's Nexium vs Prevacid
26 July 2006
Japan stock market week to July 3, 2006
10 July 2006
Japan stock market week to June 26, 2006
3 July 2006
Takeda's 2005/6 income reaches 313.2B yen
22 May 2006
Japan stock market week to April 24, 2006
1 May 2006
Japan's pharma licks its wounds after NHI cuts
13 March 2006
Japan stock market week to March 6, 2006
13 March 2006
Japan recalculates eight drug ingredients due to high sales
27 February 2006
Takeda 's income rises 14.4% in 1st 3 fiscal qtrs
20 February 2006
Japan stock market week to Jan 30, 2006
6 February 2006
Abbott:13.4% 4th-qtr 2005 EPS growth, as expected
6 February 2006
Wyeth's Zoton FasTab approved as test and treat drug in Scotland
16 January 2006
TAP terminates sub-license deal with Santarus
16 January 2006
Japan stock market 3 weeks to Jan 2, 2006
9 January 2006
Japan stock market week to September 5
12 September 2005
TAP's TAK-390MR enters Ph III
5 September 2005
Takeda's 1st-qtr stronger-than-expected due to volume growth
15 August 2005
Japan stock market week to July 18
25 July 2005
Japan stock market week to July 4
11 July 2005
French patent expiries to save1B euros by 2008
23 May 2005
Japan stock market week to April 18
25 April 2005
Combating generics: pharma brand defense
18 April 2005
Strong 3rd-qtr for Takeda, as Actos and candesartan expand globally
21 February 2005
Japan stock market week to January 24
31 January 2005
Tokyo pharma stocks - week to October 4
11 October 2004
Flamel and Tap enter licensing deal
27 September 2004
Takeda on lookout for next blockbuster
23 August 2004
Global Rx drug prices up 8% in year to June 2004
23 August 2004
Tokyo pharma stocks - week to August 2
9 August 2004
Tokyo pharma stocks - week to july 12
19 July 2004
Abbott's 2nd-qtr 2004 sales rise 14%
19 July 2004
Expanded use for TAP's Prevacid
5 July 2004
Tokyo pharma stocks - week to june 28
5 July 2004
Bentley gets Spanish OK for generic lansoprazole
28 June 2004
Tokyo pharma stocks - week to June 14
14 June 2004
Tokyo pharma stocks - week to April 19
26 April 2004
Tokyo pharma stocks - week to April 12
19 April 2004
Abbott sees 13.9% rise in sales for 1st-qtr 2004
19 April 2004
Spain's Basque drug "visas" slammed
9 February 2004
Tokyo pharma stocks - week to Jan 19
26 January 2004
World retail drug sales grew 8% in year to November 2003, says IMS
30 November 2003
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
